ANDA 90649, held by Aurobindo Pharma USA. Nifedipine.
As of Nov 16, 2026, ANDA 90649 (Nifedipine), held by Aurobindo Pharma USA, was first approved by FDA on Jun 21, 2010, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 21, 2010 | Original application | Approved | None posted |
| Nifedipine30MG · tablet, extended release;oral | Nifedipine | Rx |
| Nifedipine60MG · tablet, extended release;oral | Nifedipine | Rx |
| Nifedipine90MG · tablet, extended release;oral | Nifedipine | Rx |
| Feb 3, 2016 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jan 20, 2015 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jan 20, 2015 | Supplement 8Labeling · Standard review | Approved | None posted |
| Aug 16, 2013 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 29, 2012 | Supplement 5Manufacturing | Approved | None posted |
| Jul 29, 2011 | Supplement 3Labeling | Approved | None posted |
| Jun 21, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters